// April 17, 2023
USP’s Preferential Access for Regulators (PAR) Program: Supporting the Global Supply of Quality Medicines
In the U.S. and around the world, quality standards developed by the U.S.
In the U.S. and around the world, quality standards developed by the U.S.
The COVID-19 pandemic exacerbated vulnerabilities in the global medicines supply chain, leading t
by Diana Kwan, Pharm.D., USP Senior Scientist II for Healthcare Quality and Safety
The challenges posed by COVID-19 transcend international borders and require global solutions.